Journey Strategic Wealth’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$833K Buy
11,706
+1,569
+15% +$124K 0.02% 218
2025
Q4
$831K Sell
10,137
-10
-0.1% -$779 0.02% 207
2025
Q3
$762K Sell
10,147
-642
-6% -$47.9K 0.02% 211
2025
Q2
$799K Buy
10,789
+350
+3% +$24.4K 0.03% 204
2025
Q1
$843K Buy
10,439
+621
+6% +$53.4K 0.03% 150
2024
Q4
$768K Buy
9,818
+831
+9% +$70.6K 0.03% 156
2024
Q3
$843K Buy
8,987
+2,741
+44% +$230K 0.03% 151
2024
Q2
$487K Buy
6,246
+1,455
+30% +$119K 0.02% 159
2024
Q1
$436K Buy
4,791
+638
+15% +$53.1K 0.02% 144
2023
Q4
$321K Buy
+4,153
New +$291K 0.02% 131

Other funds holding GEHC

Journey Strategic Wealth's GEHC Position: Q1 2026 in Review

Journey Strategic Wealth increased its GE HealthCare (GEHC) stake by 15% in Q1 2026, buying an estimated $124K and bringing the position to 11,706 shares worth $833K. The position accounts for 0.02% of the portfolio, ranked #218.

Journey Strategic Wealth first reported a position in GEHC in Q4 2023 and has held it in 10 quarters since. The position peaked at $843K in Q3 2024. 1,265 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Journey Strategic Wealth held 11,706 shares of GE HealthCare worth $833K as of Q1 2026.
  • Journey Strategic Wealth bought 1,569 GE HealthCare shares in Q1 2026, an estimated $124K.
  • GE HealthCare made up 0.02% of Journey Strategic Wealth's portfolio in Q1 2026, its #218 holding.
  • Journey Strategic Wealth first reported a position in GE HealthCare in Q4 2023 and has held it in 10 quarters since.
  • Journey Strategic Wealth's GE HealthCare position peaked at $843K in Q3 2024.
  • 1,265 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Journey Strategic Wealth's 13F filing for Q1 2026, filed 15 Apr 2026.